{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:09:11Z","timestamp":1786115351477,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"DOI":"10.1186\/s13018-026-07009-6","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:35:52Z","timestamp":1780436152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of serum biomarker profiles in DDH Hip osteoarthritis versus primary hip osteoarthritis: a prospective observational study in a recent arthroplasty cohort"],"prefix":"10.1186","volume":"21","author":[{"given":"Stefan","family":"Harsanyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Schmiedlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubica","family":"Milosovicova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sona","family":"Bernatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Harsanyiova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubos","family":"Danisovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Steno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"7009_CR1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43207","volume":"15","author":"K Bakarman","year":"2023","unstructured":"Bakarman K, Alsiddiky AM, Zamzam M, et al. Developmental dysplasia of the hip (DDH): etiology, diagnosis, and management. Cureus. 2023;15:e43207. https:\/\/doi.org\/10.7759\/cureus.43207.","journal-title":"Cureus"},{"key":"7009_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2023-002080","volume":"7","author":"Z Tao","year":"2023","unstructured":"Tao Z, Wang J, Li Y, et al. Prevalence of developmental dysplasia of the hip (DDH) in infants: a systematic review and meta-analysis. BMJ Paediatr Open. 2023;7:e002080. https:\/\/doi.org\/10.1136\/bmjpo-2023-002080.","journal-title":"BMJ Paediatr Open"},{"key":"7009_CR3","doi-asserted-by":"publisher","DOI":"10.52965\/001c.157896","author":"Z Alanazi","year":"2026","unstructured":"Alanazi Z, Alanazi F, Alhazimi A, et al. Prevalence and awareness of developmental dysplasia of the hip in Northern border Saudi Arabia. Orthop Rev. 2026. https:\/\/doi.org\/10.52965\/001c.157896.","journal-title":"Orthop Rev"},{"key":"7009_CR4","first-page":"145","volume":"44","author":"KP O\u2019Connor","year":"2024","unstructured":"O\u2019Connor KP, Marshall BJ, Davison J, et al. Prevalence of radiographic hip dysplasia in the general adult population: a systematic review. Iowa Orthop J. 2024;44:145\u20139.","journal-title":"Iowa Orthop J"},{"key":"7009_CR5","first-page":"1534","volume-title":"Encyclopedia of molecular mechanisms of disease","author":"D Granchi","year":"2009","unstructured":"Granchi D, Baldini N. Osteoarthritis: developmental dysplasia of the hip. In: Encyclopedia of molecular mechanisms of disease. Berlin, Heidelberg: Springer; 2009. p. 1534\u20135."},{"key":"7009_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152194","volume":"60","author":"NS Riedstra","year":"2023","unstructured":"Riedstra NS, Vinge R, Herfkens J, et al. Acetabular dysplasia and the risk of developing hip osteoarthritis at 2,5,8, and 10 years follow-up in a prospective nationwide cohort study (CHECK). Semin Arthritis Rheum. 2023;60:152194. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152194.","journal-title":"Semin Arthritis Rheum"},{"key":"7009_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jor.2023.05.010","volume":"42","author":"PN Wolfe","year":"2023","unstructured":"Wolfe PN, Stoker AM, Crist BD, et al. Evaluation of mechanistic serum and urine biomarkers for secondary osteoarthritis associated with developmental dysplasia of the hip. J Orthop. 2023;42:24\u20139. https:\/\/doi.org\/10.1016\/j.jor.2023.05.010.","journal-title":"J Orthop"},{"key":"7009_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcot.2025.103157","volume":"69","author":"T Rajan","year":"2025","unstructured":"Rajan T, Garde A, Lavu MS, et al. Total hip arthroplasty outcomes for developmental dysplasia of the hip versus primary osteoarthritis: older age increases medical, not surgical complications. J Clin Orthop Trauma. 2025;69:103157. https:\/\/doi.org\/10.1016\/j.jcot.2025.103157.","journal-title":"J Clin Orthop Trauma"},{"key":"7009_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.arth.2023.08.026","volume":"39","author":"S Yoshino","year":"2024","unstructured":"Yoshino S, Yamaguchi R, Tanaka H, et al. Family history of developmental dysplasia of the hip is a risk factor for the progression of hip osteoarthritis. J Arthroplasty. 2024;39:393-397.e1. https:\/\/doi.org\/10.1016\/j.arth.2023.08.026.","journal-title":"J Arthroplasty"},{"key":"7009_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10067-009-1301-1","volume":"29","author":"JB Driban","year":"2010","unstructured":"Driban JB, Sitler MR, Barbe MF, Balasubramanian E. Is osteoarthritis a heterogeneous disease that can be stratified into subsets? Clin Rheumatol. 2010;29:123\u201331. https:\/\/doi.org\/10.1007\/s10067-009-1301-1.","journal-title":"Clin Rheumatol"},{"key":"7009_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.joca.2024.10.003","volume":"33","author":"HD Welhaven","year":"2025","unstructured":"Welhaven HD, Welfley AH, June RK. Osteoarthritis Year in Review 2024: molecular biomarkers of osteoarthritis. Osteoarthritis Cartilage. 2025;33:67\u201387. https:\/\/doi.org\/10.1016\/j.joca.2024.10.003.","journal-title":"Osteoarthritis Cartilage"},{"key":"7009_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.joca.2022.09.005","volume":"31","author":"FAC Rocha","year":"2023","unstructured":"Rocha FAC, Ali SA. Soluble biomarkers in osteoarthritis in 2022: year in review. Osteoarthritis Cartilage. 2023;31:167\u201376. https:\/\/doi.org\/10.1016\/j.joca.2022.09.005.","journal-title":"Osteoarthritis Cartilage"},{"key":"7009_CR13","doi-asserted-by":"crossref","unstructured":"Faber BG, Jung M, Ebsim R, et al (2026) Structural phenotypes of osteoarthritis are clinically and genetically distinct: findings from 59,539 UK Biobank participants. 2026.02.08.26345686","DOI":"10.64898\/2026.02.08.26345686"},{"key":"7009_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41413-025-00424-1","volume":"13","author":"T He","year":"2025","unstructured":"He T, Qin L, Chen S, et al. Bone-derived factors mediate crosstalk between skeletal and extra-skeletal organs. Bone Res. 2025;13:49. https:\/\/doi.org\/10.1038\/s41413-025-00424-1.","journal-title":"Bone Res"},{"key":"7009_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030806","author":"ES Vasiliadis","year":"2022","unstructured":"Vasiliadis ES, Evangelopoulos D-S, Kaspiris A, et al. The role of sclerostin in bone diseases. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11030806.","journal-title":"J Clin Med"},{"key":"7009_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12102292","volume":"12","author":"G Di Cicco","year":"2024","unstructured":"Di Cicco G, Marzano E, Mastrostefano A, et al. The pathogenetic role of RANK\/RANKL\/OPG signaling in osteoarthritis and related targeted therapies. Biomedicines. 2024;12:2292. https:\/\/doi.org\/10.3390\/biomedicines12102292.","journal-title":"Biomedicines"},{"key":"7009_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1012508","author":"R-J Bai","year":"2022","unstructured":"Bai R-J, Li Y-S, Zhang F-J. Osteopontin, a bridge links osteoarthritis and osteoporosis. Front Endocrinol. 2022. https:\/\/doi.org\/10.3389\/fendo.2022.1012508.","journal-title":"Front Endocrinol"},{"key":"7009_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X231177116","volume":"15","author":"A Sandhu","year":"2023","unstructured":"Sandhu A, Rockel JS, Lively S, Kapoor M. Emerging molecular biomarkers in osteoarthritis pathology. Ther Adv Musculoskelet Dis. 2023;15:1759720X231177116. https:\/\/doi.org\/10.1177\/1759720X231177116.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"7009_CR19","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/1756-185X.14730","volume":"26","author":"YH Lee","year":"2023","unstructured":"Lee YH, Song GG. Circulating leptin level in osteoarthritis and associations between leptin receptor polymorphisms and disease susceptibility: A meta-analysis. Int J Rheum Dis. 2023;26:1305\u201313. https:\/\/doi.org\/10.1111\/1756-185X.14730.","journal-title":"Int J Rheum Dis"},{"key":"7009_CR20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.66532","volume":"10","author":"Q Sun","year":"2021","unstructured":"Sun Q, Zhen G, Li TP, et al. Parathyroid hormone attenuates osteoarthritis pain by remodeling subchondral bone in mice. Elife. 2021;10:e66532. https:\/\/doi.org\/10.7554\/eLife.66532.","journal-title":"Elife"},{"key":"7009_CR21","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/labinvest.2017.62","volume":"97","author":"IL Tourkova","year":"2017","unstructured":"Tourkova IL, Liu L, Sutjarit N, et al. Adrenocorticotropic hormone and 1,25-dihydroxyvitamin D3 enhance human osteogenesis in vitro by synergistically accelerating the expression of bone-specific genes. Lab Invest. 2017;97:1072\u201383. https:\/\/doi.org\/10.1038\/labinvest.2017.62.","journal-title":"Lab Invest"},{"key":"7009_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2106\/00004623-197961010-00004","volume":"61","author":"JF Crowe","year":"1979","unstructured":"Crowe JF, Mani VJ, Ranawat CS. Total hip replacement in congenital dislocation and dysplasia of the hip. J Bone Joint Surg Am. 1979;61:15\u201323.","journal-title":"J Bone Joint Surg Am"},{"key":"7009_CR23","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.2106\/00004623-199912000-00014","volume":"81","author":"D T\u00f6nnis","year":"1999","unstructured":"T\u00f6nnis D, Heinecke A. Acetabular and femoral anteversion: relationship with osteoarthritis of the hip. J Bone Joint Surg Am. 1999;81:1747\u201370. https:\/\/doi.org\/10.2106\/00004623-199912000-00014.","journal-title":"J Bone Joint Surg Am"},{"key":"7009_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-4471-5451-8_30","volume-title":"Classic papers in orthopaedics","author":"PA Banaszkiewicz","year":"2014","unstructured":"Banaszkiewicz PA. Total hip replacement in congenital dislocation and dysplasia of the hip. In: Banaszkiewicz PA, Kader DF, editors. Classic papers in orthopaedics. London: Springer; 2014. p. 125\u20138."},{"key":"7009_CR25","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1097\/01.blo.0000534679.75870.5f","volume":"476","author":"B Kovalenko","year":"2018","unstructured":"Kovalenko B, Bremjit P, Fernando N. Classifications in brief: T\u00f6nnis classification of hip osteoarthritis. Clin Orthop Relat Res. 2018;476:1680\u20134. https:\/\/doi.org\/10.1097\/01.blo.0000534679.75870.5f.","journal-title":"Clin Orthop Relat Res"},{"key":"7009_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1210\/endrev\/bnac031","volume":"44","author":"M Schini","year":"2023","unstructured":"Schini M, Vilaca T, Gossiel F, et al. Bone turnover markers: Basic biology to clinical applications. Endocr Rev. 2023;44:417\u201373. https:\/\/doi.org\/10.1210\/endrev\/bnac031.","journal-title":"Endocr Rev"},{"key":"7009_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-020-03610-w","volume":"21","author":"J Shao","year":"2020","unstructured":"Shao J, Zhou S-S, Qu Y, et al. Correlation between bone turnover and metabolic markers with age and gender: a cross-sectional study of hospital information system data. BMC Musculoskelet Disord. 2020;21:603. https:\/\/doi.org\/10.1186\/s12891-020-03610-w.","journal-title":"BMC Musculoskelet Disord"},{"key":"7009_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10067-020-05150-z","volume":"40","author":"S Min","year":"2021","unstructured":"Min S, Shi T, Han X, et al. Serum levels of leptin, osteopontin, and sclerostin in patients with and without knee osteoarthritis. Clin Rheumatol. 2021;40:287\u201394. https:\/\/doi.org\/10.1007\/s10067-020-05150-z.","journal-title":"Clin Rheumatol"},{"key":"7009_CR29","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s10067-017-3690-x","volume":"36","author":"S Min","year":"2017","unstructured":"Min S, Wang C, Lu W, et al. Serum levels of the bone turnover markers dickkopf-1, osteoprotegerin, and TNF-\u03b1 in knee osteoarthritis patients. Clin Rheumatol. 2017;36:2351\u20138. https:\/\/doi.org\/10.1007\/s10067-017-3690-x.","journal-title":"Clin Rheumatol"},{"key":"7009_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s43166-020-00019-0","volume":"47","author":"NH Ibrahim","year":"2020","unstructured":"Ibrahim NH, Abdel-Monem SM, Elbarashy A-WSE, et al. Study of serum and synovial fluid Dickkopf-1 levels in patients with primary osteoarthritis of the knee joint in correlation with disease activity and severity. Egypt Rheumatol. 2020;47:13. https:\/\/doi.org\/10.1186\/s43166-020-00019-0.","journal-title":"Egypt Rheumatol"},{"key":"7009_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46663-4","volume":"15","author":"RL Nielsen","year":"2024","unstructured":"Nielsen RL, Monfeuga T, Kitchen RR, et al. Data-driven identification of predictive risk biomarkers for subgroups of osteoarthritis using interpretable machine learning. Nat Commun. 2024;15:2817. https:\/\/doi.org\/10.1038\/s41467-024-46663-4.","journal-title":"Nat Commun"},{"key":"7009_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123224","volume":"10","author":"P Zhang","year":"2015","unstructured":"Zhang P, Zhong Z-H, Yu H-T, Liu B. Significance of increased Leptin expression in osteoarthritis patients. PLoS ONE. 2015;10:e0123224. https:\/\/doi.org\/10.1371\/journal.pone.0123224.","journal-title":"PLoS ONE"},{"key":"7009_CR33","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1093\/rheumatology\/keab479","volume":"61","author":"J Zhu","year":"2022","unstructured":"Zhu J, Ruan G, Cen H, et al. Association of serum levels of inflammatory markers and adipokines with joint symptoms and structures in participants with knee osteoarthritis. Rheumatology Oxford. 2022;61:1044\u201352. https:\/\/doi.org\/10.1093\/rheumatology\/keab479.","journal-title":"Rheumatology Oxford"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-026-07009-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-026-07009-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-026-07009-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T02:29:50Z","timestamp":1785983390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13018-026-07009-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7009"],"URL":"https:\/\/doi.org\/10.1186\/s13018-026-07009-6","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the University Hospital in Bratislava, St. Cyril and Methodius Hospital (No. EK 1\/5\/2025; approval date: 29 May 2025). Informed consent was obtained from all subjects involved in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"476"}}